Research status of artificial intelligence in the diagnosis of renal cell carcinoma
10.3760/cma.j.cn112330-20190807-00357
- VernacularTitle:人工智能在肾细胞癌诊断中的研究现状
- Author:
Weixing JIANG
1
;
Shan ZHENG
;
Jianzhong SHOU
;
Jianhui MA
Author Information
1. 国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院 北京协和医学院肿瘤医院泌尿外科，北京 100021
- From:
Chinese Journal of Urology
2020;41(3):233-236
- CountryChina
- Language:Chinese
-
Abstract:
At present, the application of artificial intelligence in the diagnosis of renal cell carcinoma (RCC) is still at an early stage. There were more reports of imaging diagnosis than pathology. Studies of imaging diagnosis mainly focused on using artificial intelligence to identify benign and malignant renal tumors and predict pathological types of RCC by computed tomography. However, there were no reports of artificial intelligence in diagnosing RCC by magnetic resonance imaging. Studies of pathological diagnosis were mainly about the classification of the nucleus. In the future, artificial intelligence has great development potential in the diagnosis of RCC, and further research is needed.
